Exercise for Type 2 Diabetes
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to explore how exercise affects blood flow and metabolic health in people with type 2 diabetes, focusing on tiny particles called extracellular vesicles (EVs) that may influence heart health. The researchers will determine if exercise can alter how EVs impact individuals with type 2 diabetes, potentially aiding in the development of better treatments for heart disease linked to diabetes. Ideal participants include those with type 2 diabetes who are overweight and not currently exercising more than 150 minutes a week. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could lead to improved heart health treatments for those with type 2 diabetes.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it excludes participants who are taking certain medications like vasoactive drugs. If you're on medications like metformin or GLP-1 agonists, you must have been on them for at least a year to participate.
What prior data suggests that exercise is safe for people with type 2 diabetes?
Research has shown that exercise is generally safe and beneficial for people with type 2 diabetes. Studies indicate that various types of exercise, such as aerobic activities (like walking or cycling) and resistance training (like lifting weights), can enhance strength, lower blood pressure, and improve insulin use. This is crucial for managing diabetes.
For individuals with obesity who have normal blood sugar levels, exercise remains safe and advantageous. Regular aerobic exercise can reduce body fat and waist size, enhancing overall health and lowering the risk of heart and blood vessel issues.
These findings suggest that exercise is a safe and effective way to improve health for both groups. Reports of serious side effects are rare, making it a promising option for many people.12345Why are researchers excited about this trial?
Researchers are excited about using exercise as a treatment for type 2 diabetes because it provides a non-pharmaceutical approach that can enhance overall health while managing the condition. Unlike current treatments like metformin or insulin, which focus on regulating blood sugar levels through medication, exercise improves insulin sensitivity and glucose metabolism naturally. Additionally, engaging in regular, high-intensity workouts, as proposed in this trial, can help with weight management and cardiovascular health, which are crucial for individuals with diabetes. By potentially reducing reliance on medications, this approach offers a holistic way to manage diabetes and improve quality of life.
What evidence suggests that exercise might be an effective treatment for type 2 diabetes?
This trial will evaluate the effects of exercise on different participant groups. Studies have shown that exercise can be very effective for people with type 2 diabetes. Participants with obesity and type 2 diabetes in this trial will engage in supervised exercise sessions. Regular aerobic exercise, like walking or cycling, helps control blood sugar levels. Strength exercises, such as weight lifting, improve how the body uses insulin, which is important for managing blood sugar. Research also shows that exercise aids weight loss and improves how the body processes fat in people with obesity. Overall, exercise is an important tool for managing both type 2 diabetes and obesity.24678
Who Is on the Research Team?
Steven K Malin, PhD
Principal Investigator
Rutgers University - New Brunswick
Are You a Good Fit for This Trial?
This trial is for individuals with Type 2 Diabetes and obesity, aiming to understand how extracellular vesicles (EVs) affect cardiovascular disease related to diabetes. Participants should be interested in how exercise might influence their blood flow and metabolic health.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo supervised exercise training sessions at 85% VO2max, expending approximately 400 kcal per session
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Exercise
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rutgers, The State University of New Jersey
Lead Sponsor
University of Virginia
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator